This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
As we step into 2024, the lifesciences continue to evolve at an unprecedented pace, driven by technological innovation, a deeper understanding of human biology and the application of new technologies in areas like drug development and health wearables. These companies are at various stages of research and clinical trials.
By Luisa Sterkel & Joana Loureiro , Tenthpin Consultants The promise and potential of cell and gene therapies (CGT) has emerged in the recent past and currently over 1.500 CGT are registered for clinical trials holding great hope for the treatment of challenging and uncurable diseases.
Jupiter Neurosciences, a clinical-stage pharmacompany specializing in neuroinflammation, made its public market debut with an initial public offering (IPO) on the Nasdaq Capital Market under the symbol “JUNS.” ” The company priced 2,750,000 shares of common stock at $4.00
Built under a government tender, AION Labs comprises four large international pharmacompanies – AstraZeneca , Merck, Pfizer , and Teva – and another core partner, the Israel Biotech Fund. Yerushalmi states there are numerous ways AI can support the pharma process – from clinical trials to patient stratification.
Across the industry, pharmacompanies are turning to AI and real-world data to address many of the challenges of running clinical trials. Can the combined potential of new AI technologies and real-world patient data hold the key to overcoming the challenges in clinical trial design that have historically led to trial failure?
And on February 19, join An Insider’s Look: How Syneos Health is Shortening the Distance from Lab to Life in Clinical Trials for key industry HR insights for jobseekers. The company is focused on helping develop and deliver therapeutics to patients by leading clinical trials globally.
Ontario, Canada’s largest province by population, is stepping up its commitment to the lifesciences sector with an investment of $40 million. The $40 million will come from the Venture Ontario Fund, which is dedicated to helping Ontario lifesciencescompanies and biomanufacturers innovate, grow and compete in global markets.
The last three years in pharma have seen a growing awareness of and dissatisfaction with a trend that has plagued the industry for its whole life: Nondiverse and unrepresentative clinical trials, which lead to incomplete data and compounded health disparity for minority populations.
Following the merger, NewAmsterdam Pharma CEO Dr Michael Davidson will lead the newly formed holding company, which is expected to be named NewAmsterdam PharmaCompany. In January last year, NewAmsterdam Pharma raised $196m in a Series A funding round to support the full Phase III development of obicetrapib.
The COVID-19 pandemic has catalysed significant changes in the way pharma develops drugs, particularly in the clinical trial space. Hybrid or decentralised clinical trials (DCTs) have gained traction as technology, infrastructure and knowledge have evolved to support their use. Source: Izmailova et al, 2017.
In this interview, Xtalks spoke with experts from eClinical Solutions , Katrina Rice, Chief Delivery Officer, Data Services; and Diane Lacroix, Vice President, Clinical Data Management, about clinical data management for modern day digital clinical trials. Clinical trials aim to see whether a new investigational drug is safe and effective.
The UK’s unique offering as a lifesciences research hub helped convince US biotech Novavax to develop its COVID-19 jab there, according to the head of the country’s Vaccines Taskforce. . If you look at the development, we signed 15,000 people in six weeks in a trial set up by the NHS.
Designed to explain either the risk management plan (RMP) or clinical trial results (CTR) in a way that a child can understand, lay summaries are now a required document for all clinical trials in the European Union (EU) following changes to EU Clinical Trials Regulations (EU-CTR) regulations earlier this year.
Josh Sackman, president and co-founder of AppliedVR, and Web Sun, president and co-founder of Komodo Health, relay how their newly formed collaboration reshapes the clinical trial process by using data, helping to cut costs and allowing for evaluation of broader patient populations. . Distinct offerings.
The annual peer-reviewed awards program from the publisher of Fierce Biotech and Fierce Pharma highlights companies that have demonstrated innovative solutions, technologies, and services and have the potential to make the greatest impact for biotech and pharmacompanies.?. 2020 Accolades. About Fierce Innovation Awards.
From Bristol-Myers Squibbs monumental acquisition of Celgene to Pfizers recent purchase of Seagen, these deals illustrate the strategies and ambitions driving innovation in lifesciences. Actavis Acquisition of Allergan Deal value : $70.5
The competition highlights companies that demonstrated innovative solutions, technologies, and services that have the potential to make the greatest impact for biotech and pharmacompanies. The company was selected for its industry leading Virtual Care Management (VCM) program. To learn more about VirTrial, visit [link].
There is a growing pipeline of psychedelic therapies and an expanding body of science to suggest that they may be able to provide an alternative to existing mental health treatments. The number of active clinical trials studying psilocybin alone has increased more than three-fold from 2017. A psychedelic renaissance.
Clinical trials are essential for the development of new treatments for rare diseases, but they can be complex and challenging to execute. Patient input is a crucial component of rare disease clinical trials, as it can provide valuable insights into the patient experience and inform decisions about study design and implementation.
, revealing a multitude of diverse strategies for pharmaceutical companies to remain conscious of their global impacts. GlobalData is the parent company of Pharmaceutical Technology. These principles also aim to allow an acknowledgement of Black and brown mistrust of clinical trials. Reaching social and governance goals.
ECAs are being used to support the primary approval, label expansion of their assets and even go/no-go decisions for trials. For the innovators and early adopters of the lifesciences industry, engineering a regulatory-grade ECA can be daunting. Myth 1: There are too many challenges with adopting an ECA.
Armed with these insights, lifesciencescompanies can develop patient-centric solutions that will lead to more successful products. Taking an engaged approach has clear benefits, including improved trial retention and development of PROs that can support market-entry and market access. Read the full article here.
PPAR agonists have shown high potential in PBC treatment and diabetes research , particularly for their anti-inflammatory and metabolic effects, which not only improve symptoms but also enhance quality of life. PPAR drugs have been shown to alleviate pruritus, a debilitating itch that develops in up to 70 percent of PBC patients.
Veeva Systems invited pharmaphorum to attend its industry summit in Madrid this week, a huge event that gathered together over 1,000 individuals from lifesciences and pharma. The question is, how can the journey there be accelerated, when on the horizon awaits a lifesciences future very much immersed in speciality medicine?
It powers drug discovery, clinical trials, and operational performance. Pharmacompanies generate lots of data and bring in other data to support their actions but not all of it gets used which is where we come in,” says Thomas Kurian, head of new markets at Treasure Data, which powers some of the largest companies in pharmaceuticals.
One widely adopted and valuable health technology is telecommunications, which allows both physicians to maintain a high level of care than they otherwise could have during the pandemic and pharmacompanies to continue clinical trials. But one thing is clear already: there’s no going back to the old ways.”.
The DISC is the biggest investment AZ has ever made, and has been hailed by the pharmacompany’s chief executive Pascal Soriot as the centrepiece of what he believes could one day become a biotech hub to rival Boston and San Francisco in the US.
From telehealth to digital trials, customer engagement to healthcare data, Healthware Group outlines the key trends that are expected to shake up digital health this year. There are several important aspects to these shifts for pharma, biotech and medical device companies, so what can we expect to see over the next 12 months and beyond?
“We had over 100 companies go public in the sector in 2020 and 2021. Many of those companies were uncharacteristically early in development,” notes Barbara Ryan, senior advisor of LifeSciences at Ernst & Young. Quoting EY’s annual Firepower Report , Ryan says pharmacompanies hold $1.4
However, pharmacompanies have taken the lead to expand in the Fecal Incontinence therapy market. Pharmacompanies such as Cook MyoSite, 9 Meters Biopharma, Palette LifeSciences, and others are developing novel and effective therapies to expand the FI therapeutics market.
Inflation Reduction Act Speaking during the keynote panel “FDA & ARPA-H: LifeSciences, Biopharma & Medtech Priorities in a New Year”, Califf discussed the Inflation Reduction Act of August 2022, which aims to lower prescription drug prices. That leaves three years for pharmacompanies to prepare.
With vaccine trials for COVID-19 ramping up and entering late stages, Johnson & Johnson has announced plans for what will be the largest Phase III trial so far for a vaccine against the novel coronavirus. This is double the enrollment that vaccine makers Moderna and Pfizer have planned for their Phase III trials.
“Because digital permeates every aspect of the industry, and people are often talking about digital and maybe talking about very different things, I think about the journey of healthcare and lifesciencecompanies in three stages,” he explained. The first stage of digital transformation was really all about communications.
The Toronto-based company already counts many of the world’s largest pharmacompanies among its customers, using its platform for a range of tasks such as improving reagent and antibody selection to help scientists run more successful experiments, drawing on data from published studies and organisations’ internal databases.
XTALKS WEBINAR: Environmental Sustainability and the Supply of Medicines for Clinical Trials Live and On-Demand: Thursday, January 16, 2025, at 10am EST (4pm CET/EU-Central) Register for this free webinar to learn how major pharmacompanies are working towards environmental sustainability and reducing their environmental impact.
“Exploring novel, clinical trial development processes within our organisation has been beneficial and enlightening.” Sumitomo Pharma is a much bigger company, but they understand the science associated with the conditions we’re looking to build interventions for and the regulatory environment.
Investigation of the possibility of VAED is crucial during clinical trials for decision-making on vaccine licensing by regulatory agencies. In the majority of cases, the risk of VAED is brought to light during preclinical stages or early clinical trial phases.
In 2021, Komodo acquired two companies: Mavens, a developer of cloud-based software used for speciality biotech and pharmacompanies, and Breakaway Partners, a market access software company targeting the lifesciences industry. About the author.
Early detection can significantly help improve the longevity and quality of life of FOP patients. Safety and Effectiveness of Sohonos The Phase III MOVE trial evaluated the safety and efficacy of palovarotene in decreasing new HO in participants with FOP. The Phase III trial consisted of three parts, with 107 participants enrolled.
Over the years, his career has evolved from routine case processing at large pharmacompanies to a more strategic role in smaller settings, where he feels his impact more directly. I realized that ensuring the safe use of medications was not just a job, but a mission,” he reflects.
As a result, 2022 saw a breakthrough when the first ever computationally designed antibody created by Israel-based Biolojic design entered clinical trial , further fuelling the interest of biopharma companies. Four leading pharmacompanies – AstraZeneca, Merck, Pfizer, and Teva – along with Amazon Web Services, Inc.
Other pharmacompanies may be relieved with the latest ruling, as many worried that an Amgen win may allow drugmakers that identify antibody targets to bully their way into an unfair advantage in the market. In the new trial, a jury upheld some of Amgen’s patent claims while discarding others.
Supply chain uncertainty is a challenge every clinical supply chain manager wrestles with – stemming from increasing product demand and quality, the growing complexity of clinical trial designs and a lack of visibility in the supply chain. Accelerating your clinical trial supply through digitalization.
Recently, Eli Lilly revealed promising results from a mid-stage trial, indicating that its popular drug, tirzepatide (marketed as Zepbound and Mounjaro for weight loss and diabetes, respectively), may be an effective treatment for the fatty liver disease metabolic dysfunction-associated steatohepatitis (MASH).
We organize all of the trending information in your field so you don't have to. Join 21,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content